PGT-A:
Elevating IVF Success with Genetic Insight
At our Nicosia, Cyprus clinic, we embrace the future of fertility treatment with Preimplantation Genetic Testing for Aneuploidies (PGT-A).
This cutting-edge genetic screening illuminates the genetic health of embryos, empowering us to select those with the highest potential for a successful pregnancy.
Here’s how PGT-A is revolutionizing the journey to parenthood:
An embryo inherits chromosomes from both sperm and egg, with a precise number essential for healthy development. Deviations can lead to unsuccessful implantation or miscarriage.
PGT-A scrutinizes embryos for the correct chromosomal count before transfer, offering up to a 98% accuracy in identifying viable embryos. This meticulous selection process not only enhances IVF success rates but also diminishes the likelihood of multiple pregnancies and miscarriages.
The Core Advantages of PGT-A
Miscarriage Reduction
By identifying embryos most likely to thrive, PGT-A shortens the journey to pregnancy, alleviating the emotional and physical toll of IVF failures and miscarriages.
Informed Treatment Decisions
For those facing repeated IVF challenges without known causes, PGT-A offers insights that can guide future treatment strategies.
Boosted Clinical Pregnancy Rates
Our data confirms that transferring embryos screened via PGT-A significantly elevates pregnancy rates, marking a new era in personalized fertility care.
Who Benefits from PGT-A?
PGT-A is a beacon of hope for various candidates, especially those seeking a faster route to pregnancy, individuals with a history of recurrent miscarriages, or couples facing previous IVF disappointments. It is particularly recommended for:
Individuals aged 36 and above
Couples with a history of chromosomal abnormalities
Those with multiple embryos, aiming for the transfer of embryos with confirmed chromosomal normalcy
The PGT-A Process
Embryo selection traditionally relies on morphological assessment. PGT-A allows us to delve deeper, analyzing the genetic composition to ensure the right number of chromosomes are present. This genetic screening is performed on cells from the blastocyst’s outer layer, which develops into the placenta, while the embryo itself is preserved via cryopreservation for future transfer.
PGT-A at Our Clinic: A Tailored Approach
Our clinic combines sophisticated genetic analysis with compassionate, personalized care. From your initial consultation through to the final selection of embryos for transfer, our team ensures a seamless, informed, and supportive journey.